{"id":"W1871529692","doi":"10.1111/jvh.12464","title":"Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Genentech; Merck; Eisai; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Gastroenterology; Adverse effect; Hepatitis C virus; Clinical endpoint; Randomized controlled trial; Virology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001946895,0.001309455,0.002273321,0.0003526589,0.0004721678,0.001103063,0.0008516341,0.00185138,0.006793802],"category_scores_gemma":[0.00175094,0.0007074087,0.001649908,0.0003675272,0.0008482327,0.0008024012,0.0004046117,0.002225451,0.0008517924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006889796,"about_ca_system_score_gemma":0.001075195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009726602,"about_ca_topic_score_gemma":0.002077048,"domain_scores_codex":[0.9991358,0.0005289249,0.00006908333,0.0001160638,0.00004807604,0.0001020201],"domain_scores_gemma":[0.9991488,0.0002694369,0.0002171425,0.00005404806,0.00005008124,0.000260505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9868253,0.002791671,0.0005880215,0.0005093894,0.0005934809,0.00002370574,0.00002733351,0.0001824608,0.0006729126,0.00005788711,0.0003358061,0.007392114],"study_design_scores_gemma":[0.9733665,0.02451234,0.0009133785,0.0000439176,0.0003591591,0.00002187935,0.0000133877,0.0002108781,0.000105816,0.000060926,0.0003848729,0.00000688471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802606,0.01085235,0.0003877334,0.001174022,0.001096851,0.003621273,0.0006379877,0.0000678193,0.001901343],"genre_scores_gemma":[0.9858269,0.005087083,0.0008688879,0.001308177,0.000825292,0.003476284,0.0006077894,0.00001086096,0.001988813],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006793802,"threshold_uncertainty_score":0.02272749,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03152031339558758,"score_gpt":0.3171351482487579,"score_spread":0.2856148348531704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}